Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Tango Therapeutics (NASDAQ: TNGX) announced that Adam Crystal, M.D., Ph.D., President of Research & Development, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 1:30pm ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tango Therapeutics (NASDAQ: TNGX) announced that Adam Crystal, M.D., Ph.D., President of Research & Development, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 1:30pm ET.
The event will be live webcast via the company's Investors > Events & Presentations page on the day of the presentation, and a replay will be archived on the company's website for 90 days following the presentation.
Details
News Market Reaction – TNGX
On Nov 26, the day this news came out, TNGX closed 1.80% above the previous close.
Data tracked by StockTitan Argus for the Nov 26 session.
Key Figures
- Conference edition
- 37th annual
- Piper Sandler Healthcare Conference
- Event date
- December 3, 2025
- Scheduled conference fireside chat
- Event time
- 1:30 pm ET
- Time of fireside chat
- Webcast archive
- 90 days
- Replay availability on company website
Historical Context
-
Announced Piper Sandler healthcare conference fireside chat and webcast details.
-
Jefferies Global Healthcare Conference fireside chat and webcast information.
-
Profitable Q3 2025, strong cash and positive vopimetostat clinical data.
-
Scheduled Q3 2025 results release with no accompanying conference call.
-
Underwritten offering and PIPE totaling about $225M in gross proceeds.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Adam Crystal, M.D., Ph.D., President of Research & Development at Tango Therapeutics, is scheduled to participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3 at 1:30pm ET.
The live webcast will be available under the "Events & Presentations" tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. For more information, please visit www.tangotx.com.
Investors and Media:
Elizabeth Hickin
IR@tangotx.com
media@tangotx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.